Published in Blood Weekly, March 12th, 2009
"Thirteen patients were in relapse and/or refractory and 10 patients were at stage IV. All but two of the patients had an objective response to L-asparaginase-based treatment. Seven patients reached complete remission and only two relapsed. These data, although retrospective, confirm the excellent...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.